Xiang, Cheng et al. published their research in Frontiers in Pharmacology in 2022 |CAS: 2358-84-1

The Article related to ligusticum chuanxiong pharmacol mol docking osteoarthritis, mapk pathway, ligusticum chuanxiong, molecular docking, network pharmacology, osteoarthritis, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

Xiang, Cheng; Liao, Yilin; Chen, Zhuoyuan; Xiao, Bo; Zhao, Ziyue; Li, Aoyu; Xia, Yu; Wang, Pingxiao; Li, Hui; Xiao, Tao published an article in 2022, the title of the article was Network pharmacology and molecular docking to elucidate the potential mechanism of ligusticum chuanxiong against osteoarthritis.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate) And the article contains the following content:

Osteoarthritis (OA) is a degenerative disease which serious affects patients. Ligusticum chuanxiong (CX) has been shown to have a certain curative effect on osteoarthritis in traditional Chinese medicine therapy. This study is based on network pharmacol. and mol. docking technol. to explore the potential mechanism of CX. Components of CX to treat osteoarthritis were screened in the TCMSP database and targets were predicted by the PharmMapper database, the osteoarthritis targets were collected from the GeneCards database, and intersection genes were found to be the possible targets of CX anti-OA. The STRING database and Cytoscape software were utilized for protein-protein interaction anal. and further screening of core targets. The Metascape database was used for KEGG and GO enrichment analyses. Then, the top 10 pathways were selected to construct “drug-compound-target-pathway-disease” network anal. Finally, mol. docking was used to analyze the binding affinity of seven compounds with core targets and TNF-α. Seven compounds with 253 non-repetitive targets of CX were screened fromthe TCMSP database and 60 potential intersection targets of CX anti-OA were found. PPI network anal. showed that the core targets were ALB, AKT1, IGF1, CASP3, MAPK1, ANXA5, and MAPK14, while GO and KEGG pathway enrichment analyses showed that the relevant biol. processes involved in the treatment of osteoarthritis by CX might include the MAPK cascade and reactive oxygen species metabolic process. The KEGG pathway anal. result was mainly associated with the MAPK signaling pathway and PI3K-AKT signaling pathway. We further docked seven ingredients with MAPK1 and MAPK14 enriched in the MAPK pathway, and TNF-α as the typical inflammatory cytokine. The results also showed good binding affinity, especially FA, which may be the most important component of CX anti-OA. Our research revealed the potential mechanism of CX in the treatment of OA, and our findings can also pave the way for subsequent basic exptl. verification and a new research direction. The experimental process involved the reaction of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)(cas: 2358-84-1).Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

The Article related to ligusticum chuanxiong pharmacol mol docking osteoarthritis, mapk pathway, ligusticum chuanxiong, molecular docking, network pharmacology, osteoarthritis, Pharmacology: Effects Of Nervous System- and Behavior-Affecting Drugs and Neuromuscular Agents and other aspects.Safety of Oxybis(ethane-2,1-diyl) bis(2-methylacrylate)

Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics